541 related articles for article (PubMed ID: 25470550)
41. Raising NAD
Walker MA; Chen H; Yadav A; Ritterhoff J; Villet O; McMillen T; Wang Y; Purcell H; Djukovic D; Raftery D; Isoherranen N; Tian R
Circulation; 2023 Dec; 148(25):2038-2057. PubMed ID: 37965787
[TBL] [Abstract][Full Text] [Related]
42. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans.
Trammell SA; Schmidt MS; Weidemann BJ; Redpath P; Jaksch F; Dellinger RW; Li Z; Abel ED; Migaud ME; Brenner C
Nat Commun; 2016 Oct; 7():12948. PubMed ID: 27721479
[TBL] [Abstract][Full Text] [Related]
43. Nicotinamide Riboside Is a Major NAD+ Precursor Vitamin in Cow Milk.
Trammell SA; Yu L; Redpath P; Migaud ME; Brenner C
J Nutr; 2016 May; 146(5):957-63. PubMed ID: 27052539
[TBL] [Abstract][Full Text] [Related]
44. The NAD(+) precursor nicotinamide riboside decreases exercise performance in rats.
Kourtzidis IA; Stoupas AT; Gioris IS; Veskoukis AS; Margaritelis NV; Tsantarliotou M; Taitzoglou I; Vrabas IS; Paschalis V; Kyparos A; Nikolaidis MG
J Int Soc Sports Nutr; 2016; 13():32. PubMed ID: 27489522
[TBL] [Abstract][Full Text] [Related]
45. Pravastatin attenuates noise-induced cochlear injury in mice.
Park JS; Kim SW; Park K; Choung YH; Jou I; Park SM
Neuroscience; 2012 Apr; 208():123-32. PubMed ID: 22366511
[TBL] [Abstract][Full Text] [Related]
46. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
47. NAD+ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents.
Harkcom WT; Ghosh AK; Sung MS; Matov A; Brown KD; Giannakakou P; Jaffrey SR
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2443-52. PubMed ID: 24889606
[TBL] [Abstract][Full Text] [Related]
48. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers.
Airhart SE; Shireman LM; Risler LJ; Anderson GD; Nagana Gowda GA; Raftery D; Tian R; Shen DD; O'Brien KD
PLoS One; 2017; 12(12):e0186459. PubMed ID: 29211728
[TBL] [Abstract][Full Text] [Related]
49. Reversing neurodegenerative hearing loss.
Harrington M
Lab Anim (NY); 2015 Jan; 44(1):3. PubMed ID: 25526043
[No Abstract] [Full Text] [Related]
50. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease.
Brakedal B; Dölle C; Riemer F; Ma Y; Nido GS; Skeie GO; Craven AR; Schwarzlmüller T; Brekke N; Diab J; Sverkeli L; Skjeie V; Varhaug K; Tysnes OB; Peng S; Haugarvoll K; Ziegler M; Grüner R; Eidelberg D; Tzoulis C
Cell Metab; 2022 Mar; 34(3):396-407.e6. PubMed ID: 35235774
[TBL] [Abstract][Full Text] [Related]
51. Protective effect of nicotinamide on high glucose/palmitate-induced glucolipotoxicity to INS-1 beta cells is attributed to its inhibitory activity to sirtuins.
Lee SJ; Choi SE; Jung IR; Lee KW; Kang Y
Arch Biochem Biophys; 2013 Jul; 535(2):187-96. PubMed ID: 23562377
[TBL] [Abstract][Full Text] [Related]
52. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss.
Kopke RD; Coleman JK; Liu J; Campbell KC; Riffenburgh RH
Laryngoscope; 2002 Sep; 112(9):1515-32. PubMed ID: 12352659
[TBL] [Abstract][Full Text] [Related]
53. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD
Elhassan YS; Kluckova K; Fletcher RS; Schmidt MS; Garten A; Doig CL; Cartwright DM; Oakey L; Burley CV; Jenkinson N; Wilson M; Lucas SJE; Akerman I; Seabright A; Lai YC; Tennant DA; Nightingale P; Wallis GA; Manolopoulos KN; Brenner C; Philp A; Lavery GG
Cell Rep; 2019 Aug; 28(7):1717-1728.e6. PubMed ID: 31412242
[TBL] [Abstract][Full Text] [Related]
54. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism.
Hirschey MD; Shimazu T; Huang JY; Schwer B; Verdin E
Cold Spring Harb Symp Quant Biol; 2011; 76():267-77. PubMed ID: 22114326
[TBL] [Abstract][Full Text] [Related]
55. Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.
Ryu WI; Shen M; Lee Y; Healy RA; Bormann MK; Cohen BM; Sonntag KC
Aging Cell; 2022 Jul; 21(7):e13658. PubMed ID: 35730144
[TBL] [Abstract][Full Text] [Related]
56. Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas.
Shackelford R; Hirsh S; Henry K; Abdel-Mageed A; Kandil E; Coppola D
Anticancer Res; 2013 Aug; 33(8):3047-52. PubMed ID: 23898059
[TBL] [Abstract][Full Text] [Related]
57. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
Wang YC; Koay YC; Pan C; Zhou Z; Tang W; Wilcox J; Li XS; Zagouras A; Marques F; Allayee H; Rey FE; Kaye DM; O'Sullivan JF; Hazen SL; Cao Y; Lusis AJ
Circ Res; 2024 Feb; 134(4):371-389. PubMed ID: 38264909
[TBL] [Abstract][Full Text] [Related]
58. Emerging Role of Nicotinamide Riboside in Health and Diseases.
Sharma C; Donu D; Cen Y
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235542
[TBL] [Abstract][Full Text] [Related]
59. Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells.
Yang T; Chan NY; Sauve AA
J Med Chem; 2007 Dec; 50(26):6458-61. PubMed ID: 18052316
[TBL] [Abstract][Full Text] [Related]
60. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD
Martens CR; Denman BA; Mazzo MR; Armstrong ML; Reisdorph N; McQueen MB; Chonchol M; Seals DR
Nat Commun; 2018 Mar; 9(1):1286. PubMed ID: 29599478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
